PYRIDINYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
申请人:FORMA Therapeutics, Inc.
公开号:US20180086733A1
公开(公告)日:2018-03-29
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:
where A, B, U, V, Z, W
1
, W
2
, W
3
, and R
1
-R
6
are described herein.